跳至主要内容
临床试验/ACTRN12622000637741
ACTRN12622000637741尚未招募未知

Studying the utility of [68Ga] FAPI PET CT in Cardiac Sarcoidosis – a pilot study

Mercy Radiology0 个研究点目标入组 10 人开始时间: 2022年5月2日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Diagnosis
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patient age >= 18 years.
  • All patients deemed by the Auckland sarcoid multidisciplinary team to have newly diagnosed, confirmed cardiac sarcoid based on histopathological/clinical/imaging data and who have had a CMR and [18F]FDG PET/CT as part of their diagnostic work up.
  • Able to give informed consent
  • Willing to use effective contraceptive methods for the duration of the study 90 days after receiving the IMP

排除标准

  • All pts in which the diagnosis could not be confirmed.
  • Pts with confirmed disease who have not had [18F]FDG PET CT or CMR
  • Patients who have started therapy for cardiac sarcoidosis.
  • Patients unable, or unwilling to consent
  • females of childbearing potential must have a negative pregnancy test on the day of treatment study initiation). Participants are considered not of child bearing potential if they are surgically sterile (i.e. they have undergone a hysterectomy, bilateral tubal ligation, or bilateral oophorectomy) or they are postmenopausal.
  • Breastfeeding mothers

研究者

相似试验